468 related articles for article (PubMed ID: 33249188)
1. Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration.
Niu X; Sang H; Wang J
J Nutr Biochem; 2021 Mar; 89():108560. PubMed ID: 33249188
[TBL] [Abstract][Full Text] [Related]
2. Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice.
Wang J; Qi Y; Niu X; Tang H; Meydani SN; Wu D
J Nutr Biochem; 2018 Apr; 54():130-139. PubMed ID: 29331869
[TBL] [Abstract][Full Text] [Related]
3. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
4. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
5. Small molecule-mediated upregulation of CCR7 ameliorates murine experimental autoimmune encephalomyelitis by accelerating T-cell homing.
Li X; Lu T; Xue W; Wang Y; Luo Q; Ge H; Tan R; Shen Y; Xu Q
Int Immunopharmacol; 2017 Dec; 53():33-41. PubMed ID: 29031145
[TBL] [Abstract][Full Text] [Related]
6. Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
Zhang F; Wei W; Chai H; Xie X
J Immunol; 2013 Feb; 190(3):1017-25. PubMed ID: 23267022
[TBL] [Abstract][Full Text] [Related]
7. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
8. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Lee SY; Goverman JM
J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG
J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673
[TBL] [Abstract][Full Text] [Related]
10. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease.
Ruland C; Renken H; Kuzmanov I; Fattahi Mehr A; Schwarte K; Cerina M; Herrmann A; Otte DM; Zimmer A; Schwab N; Meuth SG; Arolt V; Klotz L; Förster I; Scheu S; Alferink J
Brain Behav Immun; 2017 Nov; 66():382-393. PubMed ID: 28642092
[TBL] [Abstract][Full Text] [Related]
13. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
14. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
[TBL] [Abstract][Full Text] [Related]
15. Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration.
Ferrara G; Benzi A; Sturla L; Marubbi D; Frumento D; Spinelli S; Abbotto E; Ivaldi F; von Holtey M; Murone M; Nencioni A; Uccelli A; Bruzzone S
J Neuroinflammation; 2020 Jul; 17(1):228. PubMed ID: 32736564
[TBL] [Abstract][Full Text] [Related]
16. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
17. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
18. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
19. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
20. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
